Position in NVO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$731,085
+$139,410 QoQ
Shares Held
15,250
-5.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#606
of 1,348 holders
Holding Since
Jun 2022
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DE BURLO GROUP INC holds $41,576,322 across 7 Drug Manufacturers - General names. NVO ranks #4 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
26,613 | $31,920,433 | |
| 2 | ABBV |
AbbVie Inc.
|
26,039 | $6,552,453 | |
| 3 | AZN |
Astrazeneca PLC
|
5,753 | $1,090,883 | |
| 4 | NVO |
Novo Nordisk A S
This page
|
15,250 | $731,085 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
5,758 | $727,465 | |
| 6 | JNJ |
Johnson & Johnson
|
1,333 | $338,542 | |
| 7 | AMGN |
Amgen Inc
|
595 | $215,461 |
All Filings in NVO
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $731,085 | 15,250 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $591,675 | 16,100 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $19,062,700 | 374,660 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $26,699,568 | 481,160 | Shares | Sole | 2025-11-13 | |
| 2024-12-31 | $426,229 | 4,955 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $17,709,281 | 148,730 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $24,634,069 | 172,580 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $15,795,254 | 123,016 | Shares | Sole | 2024-05-13 | |
| 2022-09-30 | $298 | 3 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $26,281,211 | 235,854 | Shares | Sole | 2022-08-11 | |
| No filing history on record for this holder in this stock. | ||||||